As a pioneer and leader in plasma-derived therapies, Takeda produces immunoglobulins, albumin and coagulation factors for the treatment of rare diseases, helping patients all over the world.
Video Rating: / 5

Christophe Weber, CEO of Takeda, says there are some setbacks in research and development, but most of those drugs should fuel the company’s growth in the future.
Video Rating: / 5

Email This Post Email This Post